Skip to main content

Table 1 Reasons for study discontinuation

From: Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension

Reason

PS-DHA

Placebo

Protocol violation

2

1

Withdrawn consent

5

6

Adverse events*

5

5

Severe adverse events**

1#

1##

Sum

13

13

  1. * Adverse events are specified in Table 6
  2. ** Classified by the study physician as not related to the study treatment
  3. # Hospitalization due to hyponatremia
  4. ## Hospitalization due to atrial fibrillation and epigastric pain
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us